News - Fosun Pharma, Pharmaceutical


Popular Filters

Sirona Biochem signs LoI with leading Chinese diabetes company


Canada's Sirona Biotech (TSX VENTURE:SBM) has signed a letter of intent to provide an exclusive license…

Asia-PacificBiotechnologyDiabetesFosun PharmaLicensingPharmaceuticalSGLT2Sirona BiochemWanbang Pharma

Fosun Pharma acquires majority stake in Dongting for $93 million


Shanghai, China-based Fosun Pharma says that it has acquired 77.8% stake in central nervous system and…

Fosun PharmaHunan DongtingMergers & AcquisitionsPharmaceutical

Back to top